This content is machine translated Plaque psoriasis Current 5-year data on secukinumab A long-term extension analysis of the ERASURE and FIXTURE studies recently published in the British Journal of Dermatology demonstrates the long-lasting efficacy and safety of secukinumab in patients with moderate-to-severe…
View Post 7 min This content is machine translated Psoriasis in childhood and adolescence Secukinumab in juvenile plaque psoriasis – sustained efficacy demonstrated Treatment options for psoriasis patients in childhood and adolescence are much more limited compared to the treatment spectrum for adults. But pediatric patients can also benefit from targeted treatment. This…
